LOGIN  |  REGISTER
Chimerix

AMN Healthcare Introduces Televate™ Teletherapy Platform for Students K-12

July 30, 2024 | Last Trade: US$21.17 1.21 6.06

DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare, the nation’s leading healthcare workforce solutions company, is introducing a new teletherapy platform designed to increase access to therapy services for students nationwide. “Televate™,” as the platform is called, allows school therapists, including psychologists, speech language pathologists and others, to conduct sessions in virtual therapy rooms, manage their scheduling, attendance, referrals and document uploads all in one secure location.

“The need for school-based therapy services is increasing, while access to therapists is limited,” said Kristin Martinez, M.A., CCC-SLP, Senior Director, Teletherapy with AMN Healthcare. “Televate offers an innovative way to expand access to individualized, essential services in underserved areas and other school districts where these services are urgently needed.”

While teletherapy now is available to some students, Televate offers unique features that create a new level of care, according to Martinez. Some current student teletherapy sessions take place on platforms designed for conference calls and webinars that were not developed to support high-quality therapy and evaluation services for children. Televate, by contrast, provides features designed to increase ease of student access, while engaging and empowering students to reach their developmental and academic goals, Martinez said.

These features include capacity for individual and group sessions, second camera integration, adjustable video feeds, and collaborative tools, including a whiteboard and greenscreen. In addition, clinicians can access a therapy room with integrated materials and assessments from leading publishers to meet standardized virtual evaluation requirements.

“Televate is a high-tech resource intended to achieve a high-touch outcome,” said Patrick O’Connor, President, School Solutions with AMN Healthcare. “It provides clinicians with everything they need to perform their jobs at an extremely high level, while allowing school districts to meet mandated therapy service requirements.”

Televate will be offered at the beginning of the 2024-2025 school year. Training on the platform will be provided to both school districts and clinicians staffed by AMN Healthcare. Throughout the school year, AMN Healthcare will partner with school districts and clinicians to make further enhancements to the platform if needed to better serve student needs.

For additional information about AMN Healthcare and its school staffing and technology services, visit https://www.amnhealthcare.com.

About AMN Healthcare  

AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.

Media Contact  
Corporate Communications  
AMN Healthcare  
This email address is being protected from spambots. You need JavaScript enabled to view it.  
Investor Contact  
Randle Reece  
Senior Director, Investor Relations & Strategy  
AMN Healthcare  
(866) 861-3229 
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page